AIG
CMPX icon

American International Group’s Compass Therapeutics CMPX Stock Holding History

American International Group’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,974
Closed -$89K – 572
2024
Q1 		$89K Sell
44,974
-386
-0.9% -$667 ﹤0.01% 2585
2023
Q4 		$70.8K Sell
45,360
-184
-0.4% -$318 ﹤0.01% 2720
2023
Q3 		$89.7K Buy
45,544
+1,620
+4% +$4K ﹤0.01% 2563
2023
Q2 		$140K Buy
+43,924
New +$138K ﹤0.01% 2373

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

American International Group's CMPX Position: Q2 2024 in Review

American International Group sold out of Compass Therapeutics (CMPX) in Q2 2024, closing a stake of 44,974 shares — an estimated $89K sold.

American International Group first reported a position in CMPX in Q2 2023 and held it in 4 quarters. The position peaked at $140K in Q2 2023. 82 funds tracked by Wall St. Rank hold CMPX as of Q2 2024.

  • American International Group reported no remaining Compass Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 44,974 Compass Therapeutics shares in Q2 2024, an estimated $89K.
  • American International Group first reported a position in Compass Therapeutics in Q2 2023 and held it in 4 quarters.
  • American International Group's Compass Therapeutics position peaked at $140K in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.